Code | 7303D | ||||||||||
MA number | EU/1/20/1509/001 | ||||||||||
Product Form: | con inf 1x4 ml/100 mg (liek.inj.skl.) | ||||||||||
MA Status: | E - Valid centralised marketing authorisation | ||||||||||
Type of procedure: | EU | ||||||||||
MAH, country: | Mabxience Research SL, Spain | ||||||||||
Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 30 | ||||||||||
Container: | glass vial | ||||||||||
Route of admin.: | Intravenous use |
Prescription Status: | Medicinal product subject to restricted medical prescription. |
Legal basis: | Article 10(4) similar biological application |
MA issued: | 26.03.2021 |
Validity: | 26.03.2026 |
SmPC + PL: |
|
Safety feature | Yes |
Data update: | 19.05.2023 |